David Lamond, Director at Cortexyme, Inc. (CRTX), bought 82,590 shares at $36.34 ($2.9M) on 2021-03-04, disclosed to the SEC on 2021-03-05.
Open-market purchase of $2.9M CRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.28 | 16,621 | $570K | 19.5% |
| 2 | $34.28 | 16,621 | $570K | 19.5% |
| 3 | $35.00 | 13,310 | $466K | 16.0% |
| 4 | $36.34 | 15,969 | $580K | 19.9% |
| 5 | $36.34 | 15,969 | $580K | 19.9% |
| 6 | $36.86 | 4,100 |
| $151K |
| 5.2% |
| Total | $35.32 avg | 82,590 | $2.9M | 100% |
| Filing → |
| QNCX | BUY | 2023-12-01 | $41K | — | Filing → |
| QNCX | BUY | 2023-08-31 | $216K | — | Filing → |
| QNCX | BUY | 2023-08-17 | $620K | — | Filing → |